卷 10, 编号 3 (2022) |
Articles |
Clinical and economic evaluation of atezolizumab + vemurafenib + cobimetinib combination and nivolumab + ipilimumab combination: administration in metastatic melanoma treatment with BRAF-confirmed mutation in adult patients |
(Rus)
(Eng)
|